Brigham and Women's Hospital/Harvard Medical School - Department of Medicine, Division of Genetics Division of Genetics Department of Medicine Brigham and Women's Hospital Brigham and Women's Hospital Harvard Medical School Harvard Medical School Other information
Division of Genetics | Brigham & Women's Hospital | Harvard Medical School
Maas | Beier | Michelson | Leboulch | Cichowski | Bulyk | Sunyaev | Tishler | Kucherlapati | Church Lab Affiliates
Faculty | Research Fellows | Staff | Students | Administration
ME728.0 | BCMP370 | Genetics 205 | Genetics 316
Genetic Medicine Course Listing | Genetic Medicine Faculty | Training Overview | Genetics Rotations
Division Floor Meeting
 
Grant Information | Infrastructure FAQ
Mission | History | Goals | Programs | In the News | Future | Fundraising | Ways to Help
 


Martha Bulyk, Ph.D.
  Assistant Professor of Medicine
NRB 0466D
(617) 525-4725

Bulyk Lab
    Jaime Chapoy, Ph.D.
  Research Fellow
    Federico De Masi, Ph.D.
  Research Fellow
    Savina Jaeger, Ph.D.
  Research Fellow
    Trevor Siggers, Ph.D.
  Research Fellow
    Jason Warner, Ph.D.
  Research Fellow
    Cong Zhu, Ph.D.
  Research Fellow
    Anton Aboukhalil
  Student
    Michael Berger, B.S.
  Student
    Jonathan Fu
  Student
    Rachel McCord
  Student
    Anthony Philippakis, B.S.
  Student
    Andrew Gehrke, B.S.
  Technical Research Assistant I
How to find us>>
Research Interests

Although the human genome has been almost entirely sequenced, much still remains to be understood about how the genes in the human genome are regulated. Even general themes regarding the locations of DNA regulatory elements, such as where transcription factor (TF) binding sites are generally found, are still unknown. The interactions between TFs and their DNA binding sites are an integral part of the regulatory networks within cells. They control critical steps in development and responses to environmental stresses, and their dysfunction can contribute to the progression of various diseases. However, the sequence specificities and regulatory functions of most of the ~1850 described and predicted human TFs are currently unknown.

Using a DNA microarray technology that we developed, we have analyzed the DNA binding specificities of not only individual proteins, but also selected pools of proteins, as well as entire libraries of proteins. We are currently using a version of this technology that permits measurement of the direct binding of transcription factor DNA binding domains to microarrays spotted with coding and intergenic region DNAs. This allows us to identify genomic locations of transcription factors' DNA binding sites, and thus what genes they might regulate. These data can also be used in a predictive manner to search related genomes for locations of these regulatory sequence elements. Such data provide a highly informative connection between mRNA expression analysis, proteomics, and structural genomics.

A significant challenge imposed by the genomes of higher eukaryotes is that regulatory DNA elements can be found far upstream of promoters, as well as in introns or downstream of the genes they regulate. To this effect, we have developed strategies that employ comparative genomics methods for computational analyses and predictions of transcription factor binding sites in the mouse and human genomes. Predictions regarding the interactions between TFs and their DNA binding sites will be validated using protein binding microarray experiments, in which TFs are bound directly to DNA microarrays, as well as with chromatin immunoprecipitation microarray experiments, in which a microarray readout indicates what regions of the genome are bound in vivo by a given TF under particular culture conditions. In addition, analyses of existing chromatin immunoprecipitation microarray data are being performed to identify what sequence context features might be contributing to the regulation of which TF binding sites are bound under particular conditions. The validation of predicted sites will serve to more accurately annotate the respective TFs and to provide data on the combinatorial interactions of various TFs. The results of these experiments and analyses will be important for a better understanding of the locations and organization of regulatory DNA elements in mammalian genomes, and will permit the development of more accurate algorithms for the prediction of such elements in the human genome.

Future projects may involve combining DNA-protein interaction data with data from other genomic and proteomic approaches for deciphering the regulatory networks within cells. Such projects might examine other types of regulation, such as DNA methylation, RNA secondary structure, chromatin structure, and the role of small molecule cofactors and modifications of proteins.

Publications>>

Graduate Programs
We are involved in the following graduate programs:
  • Harvard University Biophysics Program
  • Harvard-MIT Division of Health Sciences & Technology (HST)
  • Harvard Biological & Biomedical Sciences (BBS) Program
  • Harvard University Systems Biology (SysBio) Program
And also in the:
  • MIT Undergraduate Research Opportunities Program (UROP)

Please follow links below for details on these programs.
Biophysics>> HST>> BBS>> SysBio>> UROP>>